Stock Caveat Emptor Status Changes Wednesday, October 2,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Stock Caveat Emptor Status Changes Wednesday, October 2, 2013 05:13:24 AM

Date Symbol Company Name Tier Caveat Emptor Status Security Type
Sept 30, 2013 CRUI China RuiTai International Holdings Co., Ltd. Grey Market Added Common Stock
Sept 27, 2013 OXIS OXIS International, Inc. OTC Pink No Information Added Common Stock
Sept 27, 2013 BMMCF Kbridge Energy Corp. OTCQB Removed Ordinary Shares
Sept 26, 2013 SEAOF Seaco Ltd. OTC Pink No Information Added Ordinary Shares
Sept 26, 2013 PCGR PC Group, Inc. OTC Pink No Information Added Common Stock
Sept 26, 2013 IMJX Imagexpres Corp. OTC Pink No Information Added Common Stock
Sept 25, 2013 SSIID Insight ID, Inc. OTC Pink No Information Added Common Stock
Sept 25, 2013 LFBG Left Behind Games, Inc. Grey Market Added Common Stock
Sept 24, 2013 XUII Xumanii International Holdings Corp OTCQB Removed Common Stock
Sept 24, 2013 ISWI Interactive Systems Worldwide, Inc. Grey Market Added Common Stock
Sept 24, 2013 DMAT Dematco, Inc. Grey Market Added Common Stock
Sept 24, 2013 CTQN Cash Technologies, Inc. Grey Market Added Common Stock
Sept 24, 2013 CPYE Conspiracy Entertainment Holdings, Inc. Grey Market Added Common Stock
Sept 24, 2013 BBVVF BBV Vietnam S.E.A. Acquisition Corp. Grey Market Added Ordinary Shares
Sept 24, 2013 BBVUF BBV Vietnam S.E.A. Acquisition Corp. Grey Market Added Units
Sept 24, 2013 ANTXQ AcuNetx, Inc. Grey Market Added Common Stock
Sept 24, 2013 ALLP Alliance Pharmaceutical Corp. Grey Market Added Common Stock
Sept 23, 2013 SGAE Siga Resources, Inc. OTC Pink No Information Added Common Stock
Sept 23, 2013 OODH Orion Diversified Holding Co Inc. OTC Pink Current Removed Common Stock
Sept 20, 2013 CRVH Chilco River Holdings, Inc. OTC Pink No Information Added Common Stock
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Updated Category News Views 88

Introduction to the Class Action Lawsuit Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial...

Continue Reading
FARO Technologies Revolutionizes 3D Metrology with Leap ST

Updated Category News Views 105

FARO Technologies Enhances 3D Metrology with Leap ST FARO Technologies, Inc. (NASDAQ: FARO) is pushing the boundaries of handheld scanning technology with the introduction of the Leap ST. This launch marks a significant expansion of FARO's product portfolio, positioning the company among the few firms offering a comprehensive range of portable 3D metrology solutions. Leap...

Continue Reading
Strong Financial Performance and Growth Strategies at TORM PLC

Updated Category News Views 181

TORM PLC Reports Robust Q3 2025 Financial Results TORM PLC has demonstrated remarkable resilience and adaptability, reporting its strongest quarterly results in 2025. This achievement underscores the effectiveness of TORM's integrated operating model, as highlighted by the CEO. The company continues to prioritize creating long-term value for its shareholders while...

Continue Reading
Manhattan Associates Faces Legal Challenges Amid Shareholder Losses

Updated Category News Views 304

Manhattan Associates Faces Legal Challenges Following Shareholder Loss In recent developments, Manhattan Associates, Inc. (NASDAQ: MANH) is under scrutiny as a class action lawsuit has been filed against the company. This action comes after an alarming drop in shareholder value, amounting to over $4 billion. The lawsuit is pivotal as it involves allegations of misleading...

Continue Reading
BioLife Solutions Announces Upcoming Financial Results

Updated Category News Views 91

BioLife Solutions to Share Key Financial Insights BioLife Solutions, Inc. (NASDAQ: BLFS), a pioneering developer and supplier of bioproduction products and services specializing in cell and gene therapies, is gearing up for a significant event. The company plans to release its financial results for the third quarter of 2024 after market hours on November 12, 2024. This is...

Continue Reading